Southcoast Research Center, Inc.

Miami, Florida 33144

2 studies enrolling now · 15 studies all time

What they study most

Angina Pectoris, Ankylosing Spondylitis, Atopic Dermatitis, Chronic Kidney Disease Stage 3, Lupus Erythematosus, Lupus Erythematosus, Systemic, Lupus Nephritis, Pruritus, Rheumatoid Arthritis, Rosacea, SLE; Drug, Systemic Lupus Erythematosus

Studies at this site

• A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) — Recruiting now
• Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus — Enrolling by invitation
• A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus — Running, not enrolling
• Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis — Completed
• A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis — Completed
• B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis — Completed
• A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis — Completed
• Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE — Completed
• Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders — Stopped early
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis — Completed
• A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea — Completed
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) — Completed
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina — Completed